In this study, the immunohistochemical expression of RIPK3 and AXL was assessed in a cohort of 108 patients with primary cutaneous MM in order to investigate the correlation of these two markers with clinicopathological features, with main regards to SLN status and TILs. The gene discussed is RIPK3; the disease is Miyoshi myopathy.